Catalyst Wire Dossier Catalyst Wire Dossier

PRX-102

· Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for PRX-102, covering 2018-01-08 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease [Phase 2, Phase 3]

See pricing